Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • declaes declaes Sep 22, 2013 3:29 PM Flag

    Also from fda website... Golwinpeak only one person is a liar... You

    To date, fatal reactions have been reported in approximately 0.02% of patients following the first dose of intravenous administration. The reported serious hypersensitivity reactions have occurred within 30 minutes after such administration of Omontys. There have been no reports of such reactions following subsequent dosing, or in patients who have completed their dialysis session. Since launch, more than 25,000 patients have received Omontys in the postmarketing setting. The rate of overall hypersensitivity reactions reported is approximately 0.2% with approximately a third of these being serious in nature including anaphylaxis requiring prompt medical intervention and in some cases hospitalization.

 
AFFY
0.090.0000(0.00%)Apr 28 3:29 PMEDT